Skip to content
Clinical Trials – home
Sponsor

HAL Allergy B.V.

The Netherlands J.h. Oortweg 15, 2333 CH Leiden, The Netherlands

About the sponsor

HAL Allergy B.V. focuses on moderate to severe allergic rhinitis and rhinoconjunctivitis linked to house dust mite sensitisation, including persistent nasal and ocular allergy symptoms in adults.

  • Allergic rhinitis
  • Rhinoconjunctivitis
  • House dust mite allergy

The sponsor’s clinical interest is centred on allergy-driven upper airway disease and symptom control in affected adult populations.

About Specializations

HAL Allergy B.V. runs clinical trials in conditions such as Mite allergy, Conjunctivitis, Conjunctivitis allergic, Rhinitis allergic, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Mite allergy+1

Recruiting

Safety of a rush up‑dosing regimen of dust mite allergen extract versus conventional up‑dosing in adults with dust mite rhinitis/rhinoconjunctivitis with asthma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Artemisia Vulgaris
  • Sponsor:HAL Allergy B.V.

Conjunctivitis allergic+1

Not recruiting

Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.